Home
Scholarly Works
Cost-effectiveness in France of fondaparinux...
Conference

Cost-effectiveness in France of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome: an analysis using data from OASIS-5

Authors

Sculpher MJ; Lozano-Ortega G; Sambrook JC; Ormanidhi O; Bakhai A; Flather M; Jonsson B; Mehta SR; Weintraub W; Steg G

Volume

28

Pagination

pp. 858-858

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2007

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X

Contact the Experts team